Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
BJU Int. 2012 Oct;110(8):1163-8. doi: 10.1111/j.1464-410X.2012.10990.x. Epub 2012 Mar 22.
What's known on the subject? and What does the study add? Radical cystectomy (RC) carries significant risks of morbidity and mortality. Little is known whether in-hospital outcomes are improving for RC. Using a contemporary population-based cohort, the present study suggests minimal improvement in postoperative complications and mortality overall or by hospital-volume category from 2001 to 2008. About 29% and 2% of patients undergoing RC will experience a postoperative complication or die during hospitalisation, respectively.
To characterise the contemporary trends of in-hospital complications and mortality for radical cystectomy (RC) from a contemporary population-based cohort, as patients undergoing RC for bladder cancer are at significant risk for complications and mortality and the degree to which in-hospital outcomes have changed over time is unknown.
We identified 50 625 individuals who underwent RC for bladder cancer between 2001 and 2008 from the Nationwide Inpatient Sample. Multivariable regression models were used to identify hospital and patient covariates associated with in-hospital complications and mortality and to estimate predicted probabilities of each outcome. Temporal trends of in-hospital mortality and complications were assessed by Wilcoxon rank-sum test.
The proportion of patients with in-hospital complications remained stable at 28.3% in 2001-2002 compared with 28.0% in 2007-2008 (P = 0.81 for trend). In-hospital mortality was also unchanged from 2.4% in 2001-2002 compared with 2.3% in 2007-2008 (P = 0.87 for trend). While high-volume hospitals were associated with lower odds of in-hospital complications (odds ratio [OR] 0.77, P = 0.01) and mortality (OR 0.60, P = 0.02) compared with low-volume hospitals, the predicted probabilities of in-hospital complications or mortality were unchanged within each volume category between 2001 and 2008.
In-hospital complications and mortality for RC remain unchanged from 2001 to 2008. While high-volume hospitals continue to have better outcomes, there is little evidence that postoperative mortality and morbidity are improving among low-, medium- and high-volume hospitals. Increased attention is needed to identify the modifiable aspects of postoperative care to improve in-hospital outcomes and safety for patients undergoing RC.
根治性膀胱切除术(RC)具有显著的发病率和死亡率风险。目前尚不清楚 RC 的院内治疗效果是否有所改善。本研究使用了当代人群队列,结果表明,2001 年至 2008 年期间,RC 术后并发症和死亡率总体上或按医院容量类别均无明显改善。约 29%和 2%的接受 RC 的患者在住院期间分别会出现术后并发症或死亡。
从当代人群队列中描述 RC 术后近期并发症和死亡率的变化趋势,因为膀胱癌患者接受 RC 治疗时存在发生并发症和死亡的重大风险,且无法确定院内治疗效果随时间的变化程度。
我们从全国住院患者样本中确定了 2001 年至 2008 年间接受 RC 治疗的 50625 名膀胱癌患者。采用多变量回归模型,确定与院内并发症和死亡率相关的医院和患者特征,并估计每种结局的预测概率。通过 Wilcoxon 秩和检验评估院内死亡率和并发症的时间趋势。
2001-2002 年,RC 术后出现院内并发症的患者比例稳定在 28.3%,而 2007-2008 年为 28.0%(趋势 P = 0.81)。2001-2002 年的院内死亡率为 2.4%,与 2007-2008 年的 2.3%(趋势 P = 0.87)相比,并无变化。与低容量医院相比,高容量医院的院内并发症(比值比 [OR] 0.77,P = 0.01)和死亡率(OR 0.60,P = 0.02)的可能性较低,但 2001 年至 2008 年期间,每个容量类别中院内并发症或死亡率的预测概率均无变化。
RC 的院内并发症和死亡率自 2001 年以来无明显变化。虽然高容量医院的结局仍然较好,但低、中、高容量医院的术后死亡率和发病率似乎并未改善。需要进一步关注,以确定可改善 RC 术后患者院内治疗结局和安全性的方面。